Concord Drugs

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue13.6110.2816.9937.9020.95
Expenses13.4510.0116.6937.1619.41
EBITDA1.021.100.951.492.29
Operating Profit0.650.760.641.151.94
Profit Before Tax0.160.270.300.751.54
Net Profit0.120.190.220.531.11
Financial Ratios
Operating Profit Margin7.49%10.70%5.54%3.96%10.94%
Net Profit Margin0.88%1.85%1.30%1.40%5.30%
Earning Per Share (Diluted)0.120.190.160.470.85
Dividends Per Share0.000.000.000.000.00